vs
CSW INDUSTRIALS, INC.（CSW）とSotera Health Co（SHC）の財務データ比較。上の社名をクリックして会社を切り替えられます
Sotera Health Coの直近四半期売上が大きい（$303.4M vs $233.0M、CSW INDUSTRIALS, INC.の約1.3倍）。Sotera Health Coの純利益率が高く（11.5% vs 4.4%、差は7.1%）。CSW INDUSTRIALS, INC.の前年同期比売上増加率が高い（20.3% vs 4.6%）。Sotera Health Coの直近四半期フリーキャッシュフローが多い（$52.4M vs $22.7M）。過去8四半期でSotera Health Coの売上複合成長率が高い（10.6% vs 5.1%）
Sotera Health Coは医療安全ソリューションをグローバルに提供する企業で、医療機器メーカー、製薬会社、食品・消費財企業を対象に滅菌サービス、分析検査、規制対応コンサルティングを提供し、顧客の製品安全性確保と基準準拠を支援しています。
CSW vs SHC — 直接比較
売上が大きい
SHC
1.3倍大きい
$233.0M
売上成長率が高い
CSW
+15.8%の差
4.6%
純利益率が高い
SHC
純利益率が7.1%高い
4.4%
フリーキャッシュフローが多い
SHC
FCF $29.7M多い
$22.7M
2年売上CAGRが高い
SHC
2年複合成長率
5.1%
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $233.0M | $303.4M |
| 純利益 | $10.3M | $34.8M |
| 粗利率 | 39.7% | 54.7% |
| 営業利益率 | 7.4% | 23.2% |
| 純利益率 | 4.4% | 11.5% |
| 売上前年比 | 20.3% | 4.6% |
| 純利益前年比 | -61.9% | 182.8% |
| EPS（希薄化後） | $0.62 | $0.12 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上CSWSHC
| Q4 25 | $233.0M | $303.4M | ||
| Q3 25 | $277.0M | $311.3M | ||
| Q2 25 | $263.6M | $294.3M | ||
| Q1 25 | $230.5M | $254.5M | ||
| Q4 24 | $193.6M | $290.2M | ||
| Q3 24 | $227.9M | $285.5M | ||
| Q2 24 | $226.2M | $276.6M | ||
| Q1 24 | $210.9M | $248.2M |
純利益CSWSHC
| Q4 25 | $10.3M | $34.8M | ||
| Q3 25 | $40.7M | $48.4M | ||
| Q2 25 | $40.9M | $8.0M | ||
| Q1 25 | $35.1M | $-13.3M | ||
| Q4 24 | $26.9M | $12.3M | ||
| Q3 24 | $36.1M | $17.0M | ||
| Q2 24 | $38.6M | $8.8M | ||
| Q1 24 | $31.8M | $6.3M |
粗利率CSWSHC
| Q4 25 | 39.7% | 54.7% | ||
| Q3 25 | 43.0% | 57.0% | ||
| Q2 25 | 43.8% | 56.6% | ||
| Q1 25 | 44.2% | 53.2% | ||
| Q4 24 | 41.4% | 56.6% | ||
| Q3 24 | 45.6% | 55.4% | ||
| Q2 24 | 47.5% | 55.2% | ||
| Q1 24 | 44.4% | 51.2% |
営業利益率CSWSHC
| Q4 25 | 7.4% | 23.2% | ||
| Q3 25 | 20.5% | 23.4% | ||
| Q2 25 | 20.8% | 6.4% | ||
| Q1 25 | 19.5% | -5.8% | ||
| Q4 24 | 15.3% | 30.0% | ||
| Q3 24 | 22.6% | 28.2% | ||
| Q2 24 | 24.3% | 27.8% | ||
| Q1 24 | 21.0% | 21.4% |
純利益率CSWSHC
| Q4 25 | 4.4% | 11.5% | ||
| Q3 25 | 14.7% | 15.5% | ||
| Q2 25 | 15.5% | 2.7% | ||
| Q1 25 | 15.2% | -5.2% | ||
| Q4 24 | 13.9% | 4.2% | ||
| Q3 24 | 15.8% | 6.0% | ||
| Q2 24 | 17.1% | 3.2% | ||
| Q1 24 | 15.1% | 2.5% |
EPS（希薄化後）CSWSHC
| Q4 25 | $0.62 | $0.12 | ||
| Q3 25 | $2.41 | $0.17 | ||
| Q2 25 | $2.43 | $0.03 | ||
| Q1 25 | $2.05 | $-0.05 | ||
| Q4 24 | $1.60 | $0.05 | ||
| Q3 24 | $2.26 | $0.06 | ||
| Q2 24 | $2.47 | $0.03 | ||
| Q1 24 | $2.03 | $0.02 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $40.2M | $344.6M |
| 総負債低いほど良い | — | $2.1B |
| 株主資本純資産 | $1.1B | $606.0M |
| 総資産 | $2.3B | $3.3B |
| 負債/資本比率低いほどレバレッジが低い | — | 3.53× |
8四半期トレンド — 暦四半期で整列
現金・短期投資CSWSHC
| Q4 25 | $40.2M | $344.6M | ||
| Q3 25 | $31.5M | $299.2M | ||
| Q2 25 | $38.0M | $332.4M | ||
| Q1 25 | $225.8M | $304.4M | ||
| Q4 24 | $213.8M | $277.2M | ||
| Q3 24 | $273.2M | $306.7M | ||
| Q2 24 | $18.9M | $246.1M | ||
| Q1 24 | $22.2M | $261.1M |
総負債CSWSHC
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | $800.1M | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | $166.0M | $2.2B |
株主資本CSWSHC
| Q4 25 | $1.1B | $606.0M | ||
| Q3 25 | $1.1B | $550.5M | ||
| Q2 25 | $1.1B | $511.3M | ||
| Q1 25 | $1.1B | $414.1M | ||
| Q4 24 | $1.0B | $404.9M | ||
| Q3 24 | $1.0B | $470.2M | ||
| Q2 24 | $650.2M | $422.8M | ||
| Q1 24 | $615.7M | $429.4M |
総資産CSWSHC
| Q4 25 | $2.3B | $3.3B | ||
| Q3 25 | $1.5B | $3.2B | ||
| Q2 25 | $1.5B | $3.2B | ||
| Q1 25 | $1.4B | $3.1B | ||
| Q4 24 | $1.4B | $3.1B | ||
| Q3 24 | $1.4B | $3.1B | ||
| Q2 24 | $1.1B | $3.1B | ||
| Q1 24 | $1.0B | $3.1B |
負債/資本比率CSWSHC
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.89× | ||
| Q2 25 | — | 4.34× | ||
| Q1 25 | 0.75× | 5.36× | ||
| Q4 24 | — | 5.49× | ||
| Q3 24 | — | 4.73× | ||
| Q2 24 | — | 5.26× | ||
| Q1 24 | 0.27× | 5.19× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.9M | $103.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $22.7M | $52.4M |
| FCFマージンFCF / 売上 | 9.8% | 17.3% |
| 設備投資強度設備投資 / 売上 | 2.6% | 16.7% |
| キャッシュ転換率営業CF / 純利益 | 2.81× | 2.96× |
| 直近12ヶ月FCF直近4四半期 | $162.0M | $149.2M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローCSWSHC
| Q4 25 | $28.9M | $103.1M | ||
| Q3 25 | $61.8M | $71.2M | ||
| Q2 25 | $60.6M | $57.4M | ||
| Q1 25 | $27.3M | $55.5M | ||
| Q4 24 | $11.6M | $55.7M | ||
| Q3 24 | $66.8M | $97.5M | ||
| Q2 24 | $62.7M | $61.3M | ||
| Q1 24 | $22.4M | $9.7M |
フリーキャッシュフローCSWSHC
| Q4 25 | $22.7M | $52.4M | ||
| Q3 25 | $58.7M | $35.0M | ||
| Q2 25 | $57.7M | $26.2M | ||
| Q1 25 | $22.8M | $35.6M | ||
| Q4 24 | $8.5M | $-10.2M | ||
| Q3 24 | $61.3M | $61.1M | ||
| Q2 24 | $59.6M | $19.4M | ||
| Q1 24 | $17.5M | $-25.2M |
FCFマージンCSWSHC
| Q4 25 | 9.8% | 17.3% | ||
| Q3 25 | 21.2% | 11.2% | ||
| Q2 25 | 21.9% | 8.9% | ||
| Q1 25 | 9.9% | 14.0% | ||
| Q4 24 | 4.4% | -3.5% | ||
| Q3 24 | 26.9% | 21.4% | ||
| Q2 24 | 26.3% | 7.0% | ||
| Q1 24 | 8.3% | -10.2% |
設備投資強度CSWSHC
| Q4 25 | 2.6% | 16.7% | ||
| Q3 25 | 1.1% | 11.6% | ||
| Q2 25 | 1.1% | 10.6% | ||
| Q1 25 | 2.0% | 7.8% | ||
| Q4 24 | 1.6% | 22.7% | ||
| Q3 24 | 2.4% | 12.7% | ||
| Q2 24 | 1.4% | 15.2% | ||
| Q1 24 | 2.3% | 14.1% |
キャッシュ転換率CSWSHC
| Q4 25 | 2.81× | 2.96× | ||
| Q3 25 | 1.52× | 1.47× | ||
| Q2 25 | 1.48× | 7.21× | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.43× | 4.52× | ||
| Q3 24 | 1.85× | 5.73× | ||
| Q2 24 | 1.62× | 7.00× | ||
| Q1 24 | 0.71× | 1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
SHC
| Transferred At Point In Time | $198.4M | 65% |
| Nelson Labs | $55.2M | 18% |
| Nordion | $49.8M | 16% |
